Related Experiment Video
Updated: Jun 25, 2026
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma
Weiwei Liu1, Zhong Wu, Ming Guan
1Department of Laboratory Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
Objectives:
To clarify molecular mechanisms involved in the action of pigment epithelium-derived factor (PEDF) in hormone insensitive prostate cancer cells.
Methods:
Total ribonucleic acid from untreated and PEDF-treated cells was subjected to microarray analysis using BioStar 8464 microarray. Real-time polymerase chain reaction analysis was conducted to confirm the microarray data.
Results:
Twenty-seven out of 8464 genes were found altered in both cell lines. Common gene responses altered by PEDF were identified and included genes known to alter cell signaling as well as genes involved in catalytic activity, cell proliferation, angiogenesis and apoptosis. Real-time reverse transcription polymerase chain reaction, in accordance with the microarray analysis, indicated that PEDF treatment caused an upregulation in the mRNA expression level of stanniocalcin 2, brain-specific angiogenesis inhibitor 2 and growth arrest, DNA-damage-inducible, alpha, and downregulation in the messenger ribonucleic acid level of fibroblast growth factor 3, teratocarcinoma-derived growth factor, neuropilin1, and endothelial Per/ARNT/Sim domain protein1, respectively.
Conclusions:
These findings demonstrate that PEDF administration causes significant changes in the gene expression of the prostate, providing insights into the potential role of PEDF in the treatment of prostate cancer.
Insights
Pigment epithelium-derived factor (PEDF) significantly alters gene expression in hormone-insensitive prostate cancer cells. This suggests PEDF may hold potential as a novel therapeutic agent for prostate cancer treatment.
Area of Science:
- Molecular biology
- Cancer research
- Genomics
Background:
- Prostate cancer remains a significant health concern, particularly hormone-insensitive forms.
- Pigment epithelium-derived factor (PEDF) is a protein with known biological activities, but its precise role in prostate cancer is not fully understood.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the action of PEDF in hormone-insensitive prostate cancer cells.
- To identify specific genes and pathways affected by PEDF treatment.
Main Methods:
- Microarray analysis of gene expression in PEDF-treated versus untreated prostate cancer cells.
- Real-time polymerase chain reaction (PCR) to validate microarray findings.
Main Results:
- PEDF treatment altered the expression of 27 genes out of 8464 analyzed.
- Affected genes are involved in critical cellular processes including signaling, proliferation, angiogenesis, and apoptosis.
- Specific gene expression changes included upregulation of stanniocalcin 2 and downregulation of fibroblast growth factor 3.
Conclusions:
- PEDF administration induces substantial changes in gene expression within prostate cancer cells.
- These findings highlight the potential of PEDF as a therapeutic strategy for prostate cancer.
More Related Videos
15:17Colorectal Cancer Cell Surface Protein Profiling Using an Antibody Microarray and Fluorescence Multiplexing
Published on: September 25, 2011
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
